Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |